Buerger Disease: Clinical Trials

1 trial for Buerger Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Buerger Disease: new trials by email Literature Review of Buerger Disease trials Research Report on Buerger Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)
CLBS12, SOC - Critical Limb Ischemia, Buerger Disease
Phase 2CompletedLisata Therapeutics, Inc.332017-11-012024-10-09

Narrower conditions

Chronic Limb-Threatening Ischemia (1)  ·  Thromboangiitis Obliterans (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Ischemia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peripheral Arterial Disease (1)  ·  Peripheral Vascular Diseases (1)  ·  Vascular Diseases (1)  ·  Vasculitis (1)

Interventions

Standard of Care (1)  ·  betibeglogene autotemcel (1)

Sponsors

Lisata Therapeutics, Inc. (1)

Countries

Japan (1)

Top investigators

Kristen K Buck, MD (1)